C

Cooper Companies Inc
BMV:COO

Watchlist Manager
Cooper Companies Inc
BMV:COO
Watchlist
Price: 1 479.6 MXN
Market Cap: Mex$15.5B

Net Margin

9.2%
Current
Declining
by 0.2%
vs 3-y average of 9.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
9.2%
=
Net Income
$374.9m
/
Revenue
$4.1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
9.2%
=
Net Income
Mex$374.9m
/
Revenue
$4.1B

Peer Comparison

Country Company Market Cap Net
Margin
US
Cooper Companies Inc
BMV:COO
15.5B MXN
Loading...
US
Medline Inc
NASDAQ:MDLN
58.5B USD
Loading...
JP
Hoya Corp
TSE:7741
9.1T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.1B CHF
Loading...
DK
Coloplast A/S
CSE:COLO B
120.8B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.7B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4B CHF
Loading...
KR
HLB Inc
KOSDAQ:028300
7.2T KRW
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
65th
Based on 15 072 companies
65th percentile
9.2%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Cooper Companies Inc
Glance View

In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.

COO Intrinsic Value
3 381.02 MXN
Undervaluation 56%
Intrinsic Value
Price
C
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
9.2%
=
Net Income
$374.9m
/
Revenue
$4.1B
What is Cooper Companies Inc's current Net Margin?

The current Net Margin for Cooper Companies Inc is 9.2%, which is below its 3-year median of 9.4%.

How has Net Margin changed over time?

Over the last 3 years, Cooper Companies Inc’s Net Margin has decreased from 11.7% to 9.2%. During this period, it reached a low of 7.8% on Jul 31, 2023 and a high of 11.7% on Oct 1, 2022.

Back to Top